Report Code : CVMI2501137 | Published Date : March 3, 2025

The Global Livestock Pharmaceuticals Market is undergoing a significant transformation, driven by intensifying protein demand, emerging zoonotic disease threats, and technological advancements in animal health. Valued at USD 34.2 billion in 2023, the market is projected to grow at a CAGR of 6.1%, reaching USD 55.1 billion by 2031. This comprehensive analysis examines the key factors reshaping livestock medication strategies across the beef, dairy, swine, poultry, and aquaculture sectors, with a particular focus on antibiotic stewardship programs, precision livestock farming technologies, and the growing adoption of biological alternatives.

Three fundamental forces are driving market evolution: the global push for sustainable animal protein production, increasing regulatory scrutiny of antimicrobial use, and the livestock industry's digital transformation. The report provides detailed insights into therapeutic class performance, variations in regional disease burden, and innovative drug delivery systems that are enhancing treatment efficacy while addressing resistance concerns. Special attention is given to the rapidly intensifying livestock production systems in the developing world and their unique pharmaceutical needs.

2. Market Overview

2.1 Market Definition & Scope

The livestock pharmaceuticals market encompasses veterinary medicines for:

  • Food-producing animals (XX% market share)
    • Ruminants (cattle, sheep, goats)
    • Swine
    • Poultry
    • Aquaculture species
  • Breeding stock (XX%)

Key product categories:

  • Anti-infectives (XX%)
  • Parasiticides (XX%)
  • Vaccines (20%)
  • Other pharmaceuticals (XX%)

2.2 Market Size & Forecast (2023-2031)

  • 2023 Market Size: USD 34.2 Billion
  • 2031 Projected Size: USD 55.1 Billion
  • CAGR: 6.1%
  • Livestock Population: 33 billion production animals (2023) → 42 billion (2031)

2.3 Key Market Segments

By Product Type:

  1. Antibiotics (XX% share)
    • Tetracyclines (XX%)
    • Penicillins (XX%)
    • Sulfonamides (XX%)
    • Other classes (25%)
  2. Vaccines (XX%)
    • Viral (XX%)
    • Bacterial (XX%)
    • Parasitic (15%)
  3. Antiparasitics (20%)
  4. Other Therapeutics (XX%)

By Animal Type:

  • Poultry (30%)
  • Swine (XX%)
  • Cattle (XX%)
  • Aquaculture (XX%)
  • Other Livestock (5%)

By Region:

  • Asia-Pacific (40%)
  • North America (XX%)
  • Europe (XX%)
  • Latin America (XX%)
  • Middle East & Africa (XX%)

3. Market Dynamics

3.1 Market Drivers

1. Rising Global Protein Demand

  • 70% increase in animal protein needs by 2050
  • Intensive farming systems requiring more health inputs

2. Zoonotic Disease Threats

  • African Swine Fever outbreaks in 50+ countries
  • Avian influenza strains with pandemic potential

3. Digital Livestock Management

  • Precision dosing technologies improving outcomes
  • Electronic ID systems enabling traceability

4. Aquaculture Expansion

  • 60% of fish now farmed rather than wild-caught
  • Disease challenges in high-density systems

3.2 Market Challenges

1. Antimicrobial Resistance Concerns

  • WHO critical list of medically important antimicrobials
  • 30% reduction targets in agricultural antibiotic use

2. Regulatory Fragmentation

  • Varying withdrawal periods across markets
  • Differing approval requirements

3. Counterfeit Medications

  • 15-20% market penetration in developing regions
  • Subtherapeutic dosing contributing to resistance

3.3 Market Trends

1. Antibiotic Alternatives

  • Phage therapies for bacterial infections
  • Probiotic/prebiotic gut health management

2. Extended-Release Formulations

  • 90-day parasiticides reducing handling stress
  • Injectable gels providing prolonged action

3. Combination Products

  • Vaccine + vitamin cocktails
  • Broad-spectrum antiparasitics

4. Competitive Landscape

4.1 Market Share Analysis

Company

Market Share

Key Products

Strategic Focus

Zoetis

25%

Draxxin, Simparica

Livestock leadership

Merck Animal Health

20%

Bovilis, Safe-Guard

Vaccine innovation

Boehringer Ingelheim

15%

Ingelvac, Metacam

Swine/poultry focus

Elanco

12%

Rumensin, Banamine

Antibiotic stewardship

Vetoquinol

8%

Marbocyl, Osurnia

Niche therapeutic areas

4.2 Emerging Players

  • Pharmgate: Generics specialist (30% growth)
  • Huvepharma: Feed additive pharmaceuticals
  • Ceva: Vaccine pipeline expansion

4.3 Recent Developments (2024)

  • Zoetis acquired aquaculture pharma company
  • Merck launched ASF vaccine in Vietnam
  • Elanco divested legacy antibiotics portfolio

5. Regional Analysis

5.1 Asia-Pacific (40%)

  • China largest single market
  • India fastest-growing at 9% CAGR

5.2 North America (XX%)

  • US leads in precision dosing adoption
  • Canada stringent antibiotic regulations

5.3 Europe (XX%)

  • EU Green Deal impacting farm medications
  • UK leading in antibiotic reduction

6. Future Outlook

6.1 Short-Term Projections (2025)

  • 20% market share for antibiotic alternatives
  • Electronic prescriptions becoming standard

6.2 Medium-Term Outlook (2027)

  • 50% reduction in growth promoter antibiotics
  • mRNA vaccines for livestock entering market

6.3 Long-Term Forecast (2031)

  • Precision phage therapies widely adopted
  • Real-time biomarker monitoring systems




Reasons To Buy

Image



Scope

Image

Key Players

  • Zoetis Inc.
  • Merck Animal Health
  • Elanco Animal Health Incorporated
  • Boehringer Ingelheim Animal Health GmbH
  • Ceva Santé Animale

Global Livestock Pharmaceuticals Market Report

Global Livestock Pharmaceuticals Market Report

  1. 1. Global Livestock Pharmaceuticals Market Research Report
    1. 1.1 Study Objectives
    2. 1.2 Global Livestock Pharmaceuticals Market - Overview
    3. 1.3 Reason to Read This Report
    4. 1.4 Methodology and Forecast Analysis
    2. Global Livestock Pharmaceuticals Market Research Report - Preface
    1. 2.1 Global Livestock Pharmaceuticals Market Research Report – Detailed Scope and Definitions
      1. 2.1.1 By Product Type
      2. 2.1.2 By Animal Type
      3. 2.1.3 By End-user
      4. 2.1.4 By Region
    3. Global Livestock Pharmaceuticals Market Dynamics
    1. 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
    2. 3.2. Restraints – By Product Type, By Animal Type, By End-user, By Country
    3. 3.3. Opportunities – By Product Type, By Animal Type, By End-user, By Country
    4. 3.4. Trends – By Product Type, By Animal Type, By End-user, By Country
    5. 3.5. PEST Analysis
    6. 3.6. Porters Five Rule Analysis
    7. 3.7. Company’s Share Analysis (CSA) by Region or By Country
    8. 3.8. Global Livestock Pharmaceuticals Market Research Report – DROTs Impact Analysis
    4. Global Livestock Pharmaceuticals Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
    1. 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    2. 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
    3. 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
    4. 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. Global Livestock Pharmaceuticals Market, By Product Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 5.1 Antibiotics
      1. 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 5.2 Vaccines
      1. 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 5.3 Parasiticides
      1. 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    4. 5.4 Hormonal Growth Promoters
      1. 5.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. 5.5 Others
      1. 5.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. Global Livestock Pharmaceuticals Market, By Animal Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 6.1 Cattle
      1. 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 6.2 Poultry
      1. 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 6.3 Swine
      1. 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    4. 6.4 Sheep
      1. 6.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. 6.5 Others
      1. 6.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    7. Global Livestock Pharmaceuticals Market, By End-user, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 7.1 Veterinary Clinics
      1. 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 7.2 Farms
      1. 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 7.3 Pharmaceutical Companies.
      1. 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    8. Global Livestock Pharmaceuticals Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
    1. 8.1 North America
      1. 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 8.2 Europe
      1. 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 8.3 Asia-Pacific
      1. 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    4. 8.4 Latin America
      1. 8.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. 8.5 Middle East & Africa
      1. 8.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 8.6 Global Livestock Pharmaceuticals Market - Opportunity Analysis Index, By Product Type, By Animal Type, By End-user, and Region, 2024 - 2031
    9. North America Livestock Pharmaceuticals Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 9.1 By Product Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.1.1 Antibiotics
      2. 9.1.2 Vaccines
      3. 9.1.3 Parasiticides
      4. 9.1.4 Hormonal Growth Promoters
      5. 9.1.5 Others
      9.2 By Animal Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.2.1 Cattle
      2. 9.2.2 Poultry
      3. 9.2.3 Swine
      4. 9.2.4 Sheep
      5. 9.2.5 Others
      9.3 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.3.1 Veterinary Clinics
      2. 9.3.2 Farms
      3. 9.3.3 Pharmaceutical Companies.
      9.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.4.1 United States
      2. 9.4.2 Canada
      9.5 North America Global Livestock Pharmaceuticals Market – Opportunity Analysis Index, By Product Type, By Animal Type, By End-user, and Country, 2024 - 2031
      9.6 Regional Trends Analysis
      9.7 North America Global Livestock Pharmaceuticals Market Research Report - Company Profiles
      1. 9.7.1 Company 1 (United States)
      2. 9.7.2 Company 2 (Canada)
      3. 9.7.3 Company 3 (Canada)
    10. Europe Livestock Pharmaceuticals Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 10.1 By Product Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.1.1 Antibiotics
      2. 10.1.2 Vaccines
      3. 10.1.3 Parasiticides
      4. 10.1.4 Hormonal Growth Promoters
      5. 10.1.5 Others
      10.2 By Animal Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.2.1 Cattle
      2. 10.2.2 Poultry
      3. 10.2.3 Swine
      4. 10.2.4 Sheep
      5. 10.2.5 Others
      10.3 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.3.1 Veterinary Clinics
      2. 10.3.2 Farms
      3. 10.3.3 Pharmaceutical Companies.
      10.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.4.1 Germany
      2. 10.4.2 United Kingdom
      3. 10.4.3 France
      4. 10.4.4 Spain
      5. 10.4.5 Italy
      6. 10.4.6 Russia
      7. 10.4.7 Netherlands
      8. 10.4.8 Poland
      9. 10.4.9 Rest of Europe
      10.5 Europe Global Livestock Pharmaceuticals Market – Opportunity Analysis Index, By Product Type, By Animal Type, By End-user, and Country, 2024 - 2031
      10.6 Regional Trends Analysis
      10.7 Europe Global Livestock Pharmaceuticals Market Research Report - Company Profiles
      1. 10.7.1 Company 1 (Germany)
      2. 10.7.2 Company 2 (United Kingdom)
      3. 10.7.3 Company 3 (United Kingdom)
    11. Asia-Pacific Livestock Pharmaceuticals Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 11.1 By Product Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.1.1 Antibiotics
      2. 11.1.2 Vaccines
      3. 11.1.3 Parasiticides
      4. 11.1.4 Hormonal Growth Promoters
      5. 11.1.5 Others
      11.2 By Animal Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.2.1 Cattle
      2. 11.2.2 Poultry
      3. 11.2.3 Swine
      4. 11.2.4 Sheep
      5. 11.2.5 Others
      11.3 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.3.1 Veterinary Clinics
      2. 11.3.2 Farms
      3. 11.3.3 Pharmaceutical Companies.
      11.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.4.1 China
      2. 11.4.2 Japan
      3. 11.4.3 India
      4. 11.4.4 South Korea
      5. 11.4.5 Australia & NZ
      6. 11.4.6 ASEAN
      7. 11.4.7 Rest of Asia-Pacific
      11.5 Asia-Pacific Global Livestock Pharmaceuticals Market – Opportunity Analysis Index, By Product Type, By Animal Type, By End-user, and Country, 2024 - 2031
      11.6 Regional Trends Analysis
      11.7 Asia-Pacific Global Livestock Pharmaceuticals Market Research Report - Company Profiles
      1. 11.7.1 Company 1 (China)
      2. 11.7.2 Company 2 (Japan)
      3. 11.7.3 Company 3 (Japan)
    12. Latin America Livestock Pharmaceuticals Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 12.1 By Product Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.1.1 Antibiotics
      2. 12.1.2 Vaccines
      3. 12.1.3 Parasiticides
      4. 12.1.4 Hormonal Growth Promoters
      5. 12.1.5 Others
      12.2 By Animal Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.2.1 Cattle
      2. 12.2.2 Poultry
      3. 12.2.3 Swine
      4. 12.2.4 Sheep
      5. 12.2.5 Others
      12.3 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.3.1 Veterinary Clinics
      2. 12.3.2 Farms
      3. 12.3.3 Pharmaceutical Companies.
      12.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.4.1 Brazil
      2. 12.4.2 Mexico
      3. 12.4.3 Argentina
      4. 12.4.4 Peru
      5. 12.4.5 Colombia
      6. 12.4.6 Rest of Latin America
      12.5 Latin America Global Livestock Pharmaceuticals Market – Opportunity Analysis Index, By Product Type, By Animal Type, By End-user, and Country, 2024 - 2031
      12.6 Regional Trends Analysis
      12.7 Latin America Global Livestock Pharmaceuticals Market Research Report - Company Profiles
      1. 12.7.1 Company 1 (Brazil)
      2. 12.7.2 Company 2 (Mexico)
      3. 12.7.3 Company 3 (Mexico)
    13. Middle East & Africa Livestock Pharmaceuticals Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 13.1 By Product Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.1.1 Antibiotics
      2. 13.1.2 Vaccines
      3. 13.1.3 Parasiticides
      4. 13.1.4 Hormonal Growth Promoters
      5. 13.1.5 Others
      13.2 By Animal Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.2.1 Cattle
      2. 13.2.2 Poultry
      3. 13.2.3 Swine
      4. 13.2.4 Sheep
      5. 13.2.5 Others
      13.3 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.3.1 Veterinary Clinics
      2. 13.3.2 Farms
      3. 13.3.3 Pharmaceutical Companies.
      13.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.4.1 Saudi Arabia
      2. 13.4.2 UAE
      3. 13.4.3 South Africa
      4. 13.4.4 Egypt
      5. 13.4.5 Israel
      6. 13.4.6 Rest of Middle East and Africa
      13.5 Middle East & Africa Global Livestock Pharmaceuticals Market – Opportunity Analysis Index, By Product Type, By Animal Type, By End-user, and Country, 2024 - 2031
      13.6 Regional Trends Analysis
      13.7 Middle East & Africa Global Livestock Pharmaceuticals Market Research Report - Company Profiles
      1. 13.7.1 Company 1 (Saudi Arabia)
      2. 13.7.2 Company 2 (UAE)
      3. 13.7.3 Company 3 (UAE)
    14. Competition Landscape
    1. 14.1 Strategic Dashboard of Top Market Players
      14.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
      1. 14.2.1 Zoetis Inc.
      2. 14.2.2 Merck Animal Health
      3. 14.2.3 Elanco Animal Health Incorporated
      4. 14.2.4 Boehringer Ingelheim Animal Health GmbH
      5. 14.2.5 Ceva Santé Animale
    15. Data Collection Method and Research Approach
    16. Principal Presumptions and Acronyms